Circulating FGF18 is decreased in pleural mesothelioma but not correlated with disease prognosis

Circulating FGF18 is decreased in pleural mesothelioma but not correlated with disease prognosis

Abstract Background Pleural mesothelioma (PM) is a relatively rare malignancy with limited treatment options and dismal prognosis. We have previously found elevated FGF18 expression in PM tissue specimens compared with normal mesothelium. The objective of the current study was to further explore the...

Full description

Bibliographic Details
Main Authors: Berta Mosleh, Karin Schelch, Thomas Mohr, Thomas Klikovits, Christina Wagner, Lukas Ratzinger, Yawen Dong, Katharina Sinn, Alexander Ries, Walter Berger, Bettina Grasl‐Kraupp, Konrad Hoetzenecker, Viktoria Laszlo, Balazs Dome, Balazs Hegedus, Marko Jakopovic, Mir Alireza Hoda, Michael Grusch
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:Thoracic Cancer
Subjects:
biomarker
FGF18
fibroblast growth factor 18
pleural mesothelioma
Online Access:https://doi.org/10.1111/1759-7714.15004

Internet

https://doi.org/10.1111/1759-7714.15004

Similar Items